ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Development and validation of prognostic nomograms based on De Ritis ratio and clinicopathological features for patients with stage II/III colorectal cancer

Fu, Jinming; Du, Fenqi; Tian, Tian; Huang, Hao; Zhang, Lei; Li, Dapeng; Liu, Yupeng; Zhang, Ding; Gao, Lijing; Zheng, Ting; Liu, Yanlong; Zhao, Yashuang*哈尔滨医科大学
BMC CANCER2023-7-3DOI: 10.1186/s12885-023-11125-5
8阅读
引用收藏
分享

摘要

BackgroundMetabolic derangements and systemic inflammation are related to the progression of colorectal cancer (CRC) and the prognoses of these patients. The survival of stage II and III CRC patients existed considerable heterogeneity highlighting the urgent need for new prediction models. This study aimed to develop and validate prognostic nomograms based on preoperative serum liver enzyme as well as evaluate the clinical utility.MethodsA total of 4014 stage II/III primary CRC patients pathologically diagnosed from January 2007 to December 2013 were included in this study. These patients were randomly divided into a training set (n = 2409) and a testing set (n = 1605). Univariate and multivariate Cox analyses were used to select the independent factors for predicting overall survival (OS) and disease-free survival (DFS) of stage II/III CRC patients. Next, nomograms were constructed and validated to predict the OS and DFS of individual CRC patients. The clinical utility of nomograms, tumor-node-metastasis (TNM), and the American Joint Committee on Cancer (AJCC) system was evaluated using time-dependent ROC and decision curve analyses.ResultsAmong seven preoperative serum liver enzyme markers, aspartate aminotransferase-to-alanine aminotransferase ratio (De Ritis ratio) was identified as an independent factor for predicting both OS and DFS of stage II/III CRC patients. The nomograms incorporated De Ritis ratio and significant clinicopathological features achieved good accuracy in terms of OS and DFS prediction, with C-index of 0.715 and 0.692, respectively. The calibration curve showed good agreement between prediction by nomogram and actual observation. The results of time-dependent ROC and decision curve analyses suggested that the nomograms had improved discrimination and greater clinical benefits compared with TNM and AJCC staging.ConclusionsDe Ritis ratio was an independent predictor in predicting both the OS and DFS of patients with stage II/III CRC. Nomograms based on De Ritis ratio and clinicopathological features showed better clinical utility, which is expected to help clinicians develop appropriate individual treatment strategies for patients with stage II /III CRC.

学科与关键词

关键词
Colorectal cancerPrognosisPreoperative serum liver enzyme markersDe Ritis ratioNomograms
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
BMC CANCER
发表日期
2023-07-03
卷期
第 23 卷, 第 1 期
页码
620
DOI
10.1186/s12885-023-11125-5
语言
ENGLISH
成果收录
SCIE

作者

  • F

    Fu, Jinming (第一作者)

    harbin med univ · xuzhou med univ

  • D

    Du, Fenqi

    harbin med univ

查看全部 12 位作者收起作者
  • T

    Tian, Tian

    harbin med univ

  • H

    Huang, Hao

    harbin med univ

  • Z

    Zhang, Lei

    harbin med univ

  • L

    Li, Dapeng

    harbin med univ

  • L

    Liu, Yupeng

    harbin med univ

  • Z

    Zhang, Ding

    harbin med univ

  • G

    Gao, Lijing

    harbin med univ

  • Z

    Zheng, Ting

    harbin med univ

  • L

    Liu, Yanlong

    harbin med univ

  • Z

    Zhao, Yashuang (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417